株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のマルチプレックス診断市場の将来動向

Global Multiplexed Diagnostics Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 315306
出版日 ページ情報 英文 93 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
世界のマルチプレックス診断市場の将来動向 Global Multiplexed Diagnostics Market 2014-2018
出版日: 2014年10月01日 ページ情報: 英文 93 Pages
概要

マルチプレックス診断とは、1サイクルのアッセイ(検定)手順の間に複数の被検体を解析する(ための検査機器)のことを指します。マルチプレックス診断により、一つの標本に対して複数の診断・試験を実施できます。これが開発されるまでは、1回のアッセイ手順につき一つの被検体しか検査できませんでした。マルチプレックス診断は主に研究室や診断検査室などで使用されています。特に研究室では、医薬品の創薬過程で複数の被検体を検査するのにマルチプレックス診断が使用されています。マルチプレックス診断はまた、薬物乱用検査や薬理遺伝学試験、感染症検査など、様々な用途にも使用されています。世界のマルチプレックス診断市場の2013〜2018年の年平均成長率(CAGR)は20.05%に達する見通しです。

当レポートでは、全世界のマルチプレックス診断(多重診断)市場について分析し、市場の概要や構造、市場規模の動向(今後5年間の予測値)、用途別・技法別・地域別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・考察しております。

第1章 エグゼクティブ・サマリー

第2章 略語集

第3章 分析範囲

  • 市場概要
  • 主な製品

第4章 市場分析の手法

  • 市場分析のプロセス
  • 分析手法

第5章 イントロダクション

第6章 市場環境

  • 市場概況
  • 市場規模とその予測
  • ファイブフォース分析

第7章 用途別の市場分析

  • 世界のマルチプレックス診断市場:用途別の詳細分析

第8章 技術別の市場分析

  • 中密度マルチプレックス・アッセイ(検定)市場
  • 低密度マルチプレックス・アッセイ市場
  • 高密度マルチプレックス・アッセイ市場
  • 超高密度マルチプレックス・アッセイ市場
  • 次世代型シーケンシング市場

第9章 地域別分析

  • 南北アメリカ市場
  • 欧州・中東・アフリカ(EMEA)地域市場
  • アジア太平洋地域市場

第10章 購入基準

第11章 市場の成長促進要因

第12章 促進要因とその影響力

第13章 市場の課題

第14章 促進要因・課題の影響力

第15章 市場の傾向

第16章 市場動向とその影響

第17章 ベンダー環境

  • 競争シナリオ
    • 近年の主な動向
    • 企業合併・買収(M&A)
  • 市場シェア分析
  • その他の著名なベンダー
  • Affymetrix
    • 主要データ
    • 事業概要
    • 事業分類
    • 部門別の売上高
    • 地域別の売上高
    • 事業戦略
    • 主要情報
    • SWOT分析
  • Agilent Technologies
  • bioMeriux
  • Illumina
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific

第18章 その他の関連分析

図表一覧

目次
Product Code: IRTNTR4240

About Multiplexed Diagnostics

Multiplexed diagnostics refer to equipment that are used for analyzing multiple analytes in the single cycle of the assay procedure. Multiplexed diagnostics can diagnose and run multiple tests on a specimen. These tools are evolved from diagnostic assays that screen a single analyte in a single run of the assay procedure. Multiplexed diagnostics find their use in research laboratories and diagnostics laboratories. Research and development laboratories use multiplexed assays in drug development procedures to screen multiple analytes. Multiplexed diagnostics are used in various fields such as drugs-abuse screening, pharmacogenetics, and infection testing.

TechNavio's analysts forecast the Global Multiplexed Diagnostics market to grow at a CAGR of 20.05 percent over the period 2013-2018.

Covered in this Report

The Global Multiplexed Diagnostics market can be segmented into revenue generated from various multiplexed diagnostics technologies such as: Medium Density Multiplexed Assays, Low Density Multiplexed Assays, High Density Multiplexed Assays, Very High Density Multiplexed Assays and Next-Generation Sequencing.

TechNavio's report, Global Multiplexed Diagnostics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Multiplexed Diagnostics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Affymetrix
  • Agilent Technologies
  • Biomeurix
  • F. Hoffmann-La Roche
  • Illumina
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Abbott Laboratories
  • Becton Dickinson
  • Bio-Rad Laboratories
  • Cepheid
  • Hologic
  • Luminex
  • Qaigen
  • Siemens Healthcare
  • ZOLL Medical

Market Driver

  • Technological Development

For a full, detailed list, view our report

Market Challenge

  • Accurate Diagnostics Testing

For a full, detailed list, view our report

Market Trend

  • Expanding Economies in the APAC Region

For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Application

  • 07.1. Global Multiplexed Diagnostics Market by Application

08. Market Segmentation by Technology

  • 08.1. Global Medium Density Multiplexed Assays Market
    • 08.1.1. Market Size and Forecast
  • 08.2. Global Low Density Multiplexed Assays Market
    • 08.2.1. Market Size and Forecast
  • 08.3. Global High Density Multiplexed Assays Market
    • 08.3.1. Market Size and Forecast
  • 08.4. Global Very High Density Multiplexed Assays Market
    • 08.4.1. Market Size and Forecast
  • 08.5. Global Next- Generation Sequencing Market
    • 08.5.1. Market Size and Forecast

09. Geographical Segmentation

  • 09.1. Multiplexed Diagnostics Market in the Americas
    • 09.1.1. Market Size and Forecast
  • 09.2. Multiplexed Diagnostics Market in the EMEA Region
    • 09.2.1. Market Size and Forecast
  • 09.3. Multiplexed Diagnostics Market in the APAC Region
    • 09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Market Share Analysis 2013
  • 17.3. Other Prominent Vendors
  • 17.4. Affymetrix
    • 17.4.1. Key Facts
    • 17.4.2. Business Overview
    • 17.4.3. Business Segmentation
    • 17.4.4. Business Segmentation by Revenue 2013
    • 17.4.5. Business Segmentation by Revenue 2012 and 2013
    • 17.4.6. Sales by Geography
    • 17.4.7. Business Strategy
    • 17.4.8. Key Information
    • 17.4.9. SWOT Analysis
  • 17.5. Agilent Technologies
    • 17.5.1. Key Facts
    • 17.5.2. Business Overview
    • 17.5.3. Business Segmentation by Revenue 2013
    • 17.5.4. Business Segmentation by Revenue 2012 and 2013
    • 17.5.5. Geographical Segmentation by Revenue 2013
    • 17.5.6. Business Strategy
    • 17.5.7. Recent Developments
    • 17.5.8. SWOT Analysis
  • 17.6. bioMeriux
    • 17.6.1. Key Facts
    • 17.6.2. Business Overview
    • 17.6.3. Business Segmentation by Revenue 2013
    • 17.6.4. Geographical Segmentation by Revenue 2013
    • 17.6.5. Business Strategy
    • 17.6.6. Recent Developments
    • 17.6.7. SWOT Analysis
  • 17.7. Illumina
    • 17.7.1. Key Facts
    • 17.7.2. Business Overview
    • 17.7.3. Business Segmentation
    • 17.7.4. Sales Segmentation
    • 17.7.5. Business Strategy
    • 17.7.6. Key Information
    • 17.7.7. SWOT Analysis
  • 17.8. F. Hoffmann-La Roche
    • 17.8.1. Key Facts
    • 17.8.2. Business Overview
    • 17.8.3. Business Segmentation
    • 17.8.4. Sales Segmentation
    • 17.8.5. Business Strategy
    • 17.8.6. Key Information
    • 17.8.7. SWOT Analysis
  • 17.9. Thermo Fisher Scientific
    • 17.9.1. Key Facts
    • 17.9.2. Business Overview
    • 17.9.3. Business Segmentation
    • 17.9.4. Product Segmentation by Revenue
    • 17.9.5. Sales Segmentation
    • 17.9.6. Business Strategy
    • 17.9.7. Key Information
    • 17.9.8. SWOT Analysis

18. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Multiplexed Diagnostics Market 2013-2018 (US$ million)
  • Exhibit 3: Medium Density Multiplexed Assays Market by Technology Segmentation
  • Exhibit 4: Low Density Multiplexed Assays Market by Technology Segmentation
  • Exhibit 5: High Density Multiplexed Assays Market by Technology Segmentation
  • Exhibit 6: Very High Density Multiplexed Assays Market by Technology Segmentation
  • Exhibit 7: Global Multiplexed Diagnostics Market Segmentation by Technology 2013
  • Exhibit 8: Global Medium Density Multiplexed Assays Market 2013-2018 (US$ million)
  • Exhibit 9: Global Low Density Multiplexed Assays Market 2013-2018 (US$ million)
  • Exhibit 10: Global High Density Multiplexed Assays Market 2013-2018 (US$ million)
  • Exhibit 11: Global Very High Density Multiplexed Assays Market 2013-2018 (US$ million)
  • Exhibit 12: Global Next- Generation Sequencing Market 2013-2018 (US$ million)
  • Exhibit 13: Global Multiplexed Diagnostics Market Segmentation by Technology 2013-2018
  • Exhibit 14: Global Multiplexed Diagnostics Market Segmentation by Technology 2013-2018 (US$ million)
  • Exhibit 15: Global Multiplexed Diagnostics Market by Geographical Segmentation 2013
  • Exhibit 16: Global Multiplexed Diagnostics Market by Geographical Segmentation 2013-2018
  • Exhibit 17: Multiplexed Diagnostics Market in the Americas 2013-2018 (US$ million)
  • Exhibit 18: Multiplexed Diagnostics Market in the EMEA Region 2013-2018 (US$ million)
  • Exhibit 19: Multiplexed Diagnostics Market in the APAC Region 2013-2018 (US$ million)
  • Exhibit 20: Global Multiplexed Diagnostics Market by Geographical Segmentation 2013-2018 (US$ million)
  • Exhibit 21: Affymetrix: Business Segmentation 2013
  • Exhibit 22: Affymetrix: Business Segmentation by Revenue 2013
  • Exhibit 23: Affymetrix: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 24: Affymetrix: Sales by Geography 2013
  • Exhibit 25: Agilent Technologies: Business Segmentation by Revenue 2013
  • Exhibit 26: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 27: Agilent Technologies: Geographical Segmentation by Revenue 2013
  • Exhibit 28: bioMeriux: Business Segmentation by Revenue 2013
  • Exhibit 29: bioMeriux: Geographical Segmentation by Revenue 2013
  • Exhibit 30: Illumina: Business Segmentation 2013
  • Exhibit 31: Illumina: Sales by Geography 2013
  • Exhibit 32: F. Hoffmann-La Roche: Business Segmentation 2013
  • Exhibit 33: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013 and 2012
  • Exhibit 34: F. Hoffmann-La Roche: Sales by Geography 2013 (Pharmaceuticals Division)
  • Exhibit 35: F. Hoffmann-La Roche: Sales by Geography 2013 (Diagnostics Division)
  • Exhibit 36: Thermo Fisher Scientific: Business Segmentation by Revenue 2013
  • Exhibit 37: Thermo Fisher Scientific: Product Segmentation by Revenue 2013
  • Exhibit 38: Thermo Fisher Scientific: Sales by Geography 2013
Back to Top